US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Bluelinea SA (ALBLU) 銘柄情報

Bluelinea SA (ALBLU)

0.37

0.00

(0.00%)

終了 7月5日 12:30AM

Bluelinea SA (ALBLU) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.37

( - )

買値

0.35

売値

0.38

出来高

1,068

0.36 日の範囲 0.37

0.35 52 週間の範囲 0.69

時価総額

前日終値

0.37

始値

0.37

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

2,642 €

発行済株式数

18,421,012

配当利回り

PER

-4.65

1 株当たり利益 (EPS)

-0.08

歳入

11.12M

純利益

-1.51M

Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting c... Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting caregivers and staff in shared accommodation between seniors, serviced residences, EHPADs, specialized disability centers, and health establishments. Bluelinea Société Anonyme was incorporated in 2006 and is headquartered in Versailles, France. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.bluelinea.com

本社

Versailles, France

設立

2026

Bluelinea SA is listed in the Healthcare sector of the ユーロネクスト with ticker ALBLU. The last closing price for Bluelinea was 0.37 €. Over the last year, Bluelinea shares have traded in a share price range of 0.35 € to 0.69 €.

Bluelinea currently has 18,421,012 shares in issue. The market capitalisation of Bluelinea is 6.82 € million. Bluelinea has a price to earnings ratio (PE ratio) of -4.65.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-5.12820512821	0.39	0.39	0.35	4817	0.36954951	DE
4	-0.05	-11.9047619048	0.42	0.42	0.35	2405	0.38761046	DE
12	-0.11	-22.9166666667	0.48	0.48	0.35	2705	0.42188584	DE
26	-0.12	-24.4897959184	0.49	0.5	0.35	1715	0.43899306	DE
52	-0.175	-32.1100917431	0.545	0.69	0.35	4827	0.47873292	DE
156	-1.07	-74.3055555556	1.44	1.445	0.35	3353	0.88358825	DE
260	-4.48	-92.3711340206	4.85	5.2	0.35	3452	1.39840164	DE

ALBLU - Frequently Asked Questions (FAQ)

What is the current Bluelinea SA share price?

The current share price of Bluelinea SA is 0.37 €

How many Bluelinea SA shares are in issue?

Bluelinea SA has 18,421,012 shares in issue

What is the market cap of Bluelinea SA?

The market capitalisation of Bluelinea SA is EUR 6.82M

What is the 1 year trading range for Bluelinea SA share price?

Bluelinea SA has traded in the range of 0.35 € to 0.69 € during the past year

What is the PE ratio of Bluelinea SA?

The price to earnings ratio of Bluelinea SA is -4.65

What is the cash to sales ratio of Bluelinea SA?

The cash to sales ratio of Bluelinea SA is 0.63

What is the registered address of Bluelinea SA?

The registered address for Bluelinea SA is 2-12 Parvis Colonel Arnaud Beltrame, Versailles, Ile-de-France, 78000

What is the Bluelinea SA website address?

The website address for Bluelinea SA is www.bluelinea.com

Which industry sector does Bluelinea SA operate in?

Bluelinea SA operates in the Medical Equipment & Supplies sector

SonicProphet49

SonicProphet49 6分前

Cryptocurrency Recovery Services: Why Acting Fast Can Make a Difference

Recovering Lost or Stolen Cryptocurrency: The Importance of Time

The cryptocurrency market continues to grow, bringing new opportunities for investors, traders, and businesses worldwide. Unfortunate

Philbot

Philbot 10分前

Valid points. Won't it get delisted by not paying its annual listing dues or annual filing statements? It probably should have been auto-delisted by now.

GoodGuyBill

GoodGuyBill 15分前

Thanks. Wish I could return the complement.

https://investorshub.advfn.com/uimage/uploads/2026/7/4/rlzkdBadpost.jpg

m0n

Imagine having a product since 2009 LoL.
Cant even pay the bills and continue to have decades upon decadesof $2.2 million in deficits. LOL
No One is Fooled

m0n

How many shareholders have passed away? I m aware of one but feel there’s more.
I FU S website has ionic studies from 2009. LoL
30 YEARS IS FASTLY APPROACHING! LoL
Same o Same o, Keep the awareness on the possibilities LoL.
No One is Fooled

barnyarddog

barnyarddog 27分前

AI Overview - Avalanche Treasury Co. (ticker: AVAT) is a Nasdaq-listed operating company that provides public market investors with direct exposure to the Avalanche blockchain ecosystem.

Rather than merely stockpiling digital assets, AVAT actively allocates capital across the Avalanc

m0n

Past 6 months WIP $150 &$130k LoL
Can’t even pay the bills without door knocking for SSI $$$ in January 2026LoL
What a Joke!
No One is Fooled

TightCoil

TightCoil 37分前

Glen Bradford - Looks Like Trump Team Simply Maximizing Frannie IPO (OTCMKTS:FNMAS)
Seeking Alpha - 17 hours ago

TechBullion
Could Pepeto Be the Best Crypto Presale to Buy as
Fannie Mae Opens the Door to Crypto Mortgages?
5 hours ago

weenphan

weenphan 44分前

https://www.otcmarkets.com/stock/CVALF/profile

Kool Aid Man

Kool Aid Man 45分前

Measly $44k left in the gas tank

40 million shares left to issue x .0011

No one goes public if they intend to self finance operations. The whole point is to print and sell shares to raise money...not to reward old bag holders who were conned by Miro years ago. Why split

jondoeuk

jondoeuk 46分前

Calling this the "gold standard" doesn't answer all the underlying concerns. This isn't a refinement of the original external-control analysis either. It uses a completely different set of external comparator trials. That means the reported survival estimate depends on which external patients are se

manibiotech

manibiotech 48分前

Yes we all know that . The previous external control arm patients were “external” , and the one’s in new PSM analysis are also different ‘external’ patients with patient level propensity matching ( so even better controls) and show even better treatment benefit . So again, what is the point you are

Naught

Naught 49分前

Should we expect some notices from. PAC in the very near term then...?

weenphan

weenphan 49分前

I posted on the PCHM board for over a decade. I bought PCHM as low as .0013 and sold stock as high as $5 plus. It was a once in a lifetime percentage gainer. My aliases were LMLYP, Rosesarefree and GeneandDean, which all are references to a band Ween. I'm weenphan on this board.

newflow

newflow 49分前

Ron, Dissolved vs Extinct
No Altaba distributed immediately before dissolution, can you find any company distributing value to equity holders after its complete dissolution long-form or regular Dissolution.
Gemini's Response:
It is important to clarify a key point about Delaware

DA88

Can someone explain who this guy is and why his perspective matters? Love that he is positive, but he doesn’t look like he is anything more than a shareholder.

PickStocks

PickStocks 53分前

Yes….but we do not have anything to do with Paladin. So it means nothing which is easily verified by a simple phone call….

jondoeuk

jondoeuk 57分前

Whether this particular analysis has been submitted is something nobody outside NWBO and the MHRA knows.

jondoeuk

jondoeuk 59分前

This is not simply a refinement of the published JAMA Oncology analysis. It's a different external-control analysis built from a different pool of comparator trials. The fact they constructed a propensity-score matched analysis using individual patient data from AVAGLIO, CENTRIC, and CORE, means the

ihorchu

ihorchu 1時間前

A fantastic day to remember! Since no humidity here, heat is very tolerable.

jondoeuk

jondoeuk 1時間前

'While encouraging, our clinical findings must be interpreted with caution. Even though this was a randomized clinical trial (randomization software assigned patients to TLR agonist/placebo groups), the small number of patients enrolled contributed to an imbalance in patient selection between the tr

kevindenver

kevindenver 1時間前

Nowhere in the interview was "Blarcamesine" mentioned. There was a snippet towards the end where autophagy is mentioned.

Maybe you hallucinated that this interview was related to blarcamesine?

A transcript of the interview can be found here:
https://podcasts.hap

TightCoil

TightCoil 1時間前

Yes, next week is the week we FLY

Amundi FTSE EPRA NAREIT ...

Invesco High Yield Bond ...

Quantum Critical Metals

Juventus Football Club

US Dollar vs IQD

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。